Kelly, B. J., Rupert, D., Aikin, K., Sullivan, H., Johnson, M., West, S., … Rabre, A. (2017). Development and Validation of Patient-Reported Risk, Efficacy and Benefit Measures in the Context of DTC Prescription Drug Advertising. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 26, pp. 447–448).

Kelly, Bridget J., Douglas Rupert, Kathryn Aikin, Helen Sullivan, Mihaela Johnson, Suzanne West, Brian Southwell, et al. “Development and Validation of Patient-Reported Risk, Efficacy and Benefit Measures in the Context of DTC Prescription Drug Advertising.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 26:447–48, 2017.

Kelly BJ, Rupert D, Aikin K, Sullivan H, Johnson M, West S, et al. Development and Validation of Patient-Reported Risk, Efficacy and Benefit Measures in the Context of DTC Prescription Drug Advertising. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2017. p. 447–8.

Kelly, Bridget J., et al. “Development and Validation of Patient-Reported Risk, Efficacy and Benefit Measures in the Context of DTC Prescription Drug Advertising.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 26, 2017, pp. 447–48.

Kelly BJ, Rupert D, Aikin K, Sullivan H, Johnson M, West S, Southwell B, Bann C, Mack N, Parvanta S, Peinado S, Rabre A. Development and Validation of Patient-Reported Risk, Efficacy and Benefit Measures in the Context of DTC Prescription Drug Advertising. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2017. p. 447–448.